Business Context and Reporting Period
This Form 8-K is a current report filed by OncoCyte Corporation (not Insight Molecular Diagnostics Inc.) on August 15, 2016. The filing addresses a specific corporate governance event regarding the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a personnel change and does not contain financial performance data.
Material Changes
The material change reported is the departure of a director:
- Event: Resignation of Dr. Michael D. West from the Board of Directors.
- Date: August 15, 2016.
Guidance, Outlook, and Risks
The filing includes a standard forward-looking statements disclaimer. It notes that actual results may differ materially from anticipated results due to factors detailed in the company's Form 10-K and Form 10-Q under the "Risk Factors" heading. The company disclaims any obligation to update these statements.
Investor Verification Checklist
- Verify the exact date of Dr. Michael D. West's resignation (August 15, 2016).
- Confirm the current composition of the Board of Directors following this departure.
- Review the company's most recent Form 10-K and 10-Q for detailed risk factors and financial status, as this 8-K contains no financial data.
- Check for any subsequent filings regarding the appointment of a replacement director.